3 results
The primary objective of this trial is to investigate the bias, limits of agreement and percentage error of cardiac output measurements with Vigileo FloTrac, transoesophageal doppler ultrasound, thoracic bioreactance (NICOM) with the CO obtained…
The primary objective is to assess the relative bioavailability of TMC207 after single-dose administration of 100 mg of TMC207 as water dispersible tablets or granules using a 100-mg tablet formulation as the reference, with and without food.
The study will be performed in 2 parts, Parts A and B. The purpose of the study is to investigate to what extent BN201 is tolerated. It will also be investigated how quickly and to what extent BN201 is absorbed and eliminated from the body (this is…